Don't miss an issue! Renew/subscribe for FREE today.

Sierra Dental Tool Announces New Sales Representative

Posted on Wednesday, December 27, 2023

Sierra Dental Tool, a division of RobbJack Corporation, has announced the appointment of Paul Beck as Global Channel Dealer Sales Representative, reporting to Nick Alonge, Vice President of Global Sales and Support. “I am truly honored to represent the highest quality milling tools in the industry and support customer growth and business objectives together. Knowing that RobbJack’s tools are top-of-the-line and made in the USA fills me with pride,” says Beck.

To this role, Beck will offer extensive knowledge in restorative dentistry and digital workflows. He is an Honors Graduate of New York City College of Technology of Restorative Dentistry and a Recognized Graduate of the National Board for Certification in Dental Laboratory Technology. From past roles in management with Lululemon and as a professional cheerleading coach, he has expertise in high-volume sales, customer training, and education. “I am dedicated to supporting customer goals, business growth and creating long term relationships by forming connections through reliability and trust,” Beck says. “As a former Division I college athlete, I am also thrilled to be part of a team that works together to problem solve, navigate obstacles, and achieve goals.”

In his free time, Beck enjoys traveling (18 countries and counting!), reading, exercising, and loves the water. Raised in Georgia, with a Bachelor of Fine Arts from the University of Georgia, he is a huge Dawgs fan. Currently residing and working remotely in New York City, Beck loves the abundance of restaurants and culture. “On a personal level, as someone who has worn a removable partial denture since age 9, I am thrilled to know that the work I am doing at RobbJack and Sierra Dental Tool will help other people proudly smile again,” says Beck.

Henry Schein One Earns "Best Companies to Work For" by Utah Business for Second Year in a Row

Posted on Thursday, December 21, 2023

Employees voted and top perks include unlimited PTO, 401k match and overall dynamic company culture

Henry Schein One, the world’s largest dental software and services company, announced today that for the second year in a row, it has been named to Utah Business’ “Best Companies to Work For,” an award given to select organizations deemed “best place to work” by their own employees.

As a result of anonymous employee-based surveys, companies are ranked based on several factors including flexibility, pay equity, vacation time, and management. To learn more about this distinction, click here.

“At Henry Schein One, our unique culture and strong emphasis on work-life balance continues to set us apart,” said Tanya Befus, Chief People Officer at Henry Schein One. “This award once again validates our commitment to our Team Schein Members (TSMs), who are indispensable in our success. Our values of equity, dignity, respect – and our focus on providing opportunities for personal and professional growth –ensure our TSMs continue to help our customers provide quality care to their patients.”

Specifically for Henry Schein One, TSMs coined the following perks as top-notch: fitness center with trainers, unlimited PTO, paid holidays, insurance policies and offerings, hybrid and remote work schedule, 401(k) match, and its dynamic company culture inclusive of Employee Resource Groups such as its Women’s Leadership Network (WLN).

“Our mission at Henry Schein One is to provide a forum that empowers, develops, and connects our network of women and Allies to drive business success,” said Amanda Rychtanek, Co-Chair of the WLN Chapter at Henry Schein One. “We are empowered by our executive leadership team to work alongside TSMs to foster an inclusive and vibrant workplace, all while working toward a common goal of empowering dentists to focus on patient care, ensuring practice success.”

Henry Schein One offers a range of integrated dental technology, combining practice management, patient communication, and marketing solutions to help dental practices streamline their digital workflow, so they can focus on providing the best possible patient care.  

Pearl Granted U.S. Patent for Dental Practice Data Analysis AI Technology

Posted on Thursday, December 21, 2023

Patent grants exclusive rights to the AI systems behind Pearl’s pioneering Practice Intelligence® clinical performance platform

Pearl, the global leader in dental AI solutions, today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 11,776,677 entitled “Computer Vision-Based Analysis Of Provider Data” for the exclusive rights to the computer vision system at the core of its pioneering clinical performance software, Practice Intelligence®.

This patent covers the machine learning techniques used to analyze data associated with one or more dental practices to identify missed treatment opportunities, future treatment opportunities, or provider performance metrics. Practice Intelligence® analyzes AI-detected evidence in patient radiographs in conjunction with patient treatment data to identify office and practitioner-specific patterns. Pearl’s patented system then synthesizes its findings into actionable patient health and clinical performance insights, helping to facilitate superior oral healthcare outcomes for patients, strong financial outcomes for practices, and a more productive dental care workflow.

“Practice Intelligence equips dental practices around the world with clinical performance insights essential for increasing operational efficiency and boosting practice growth,” said Ophir Tanz, Founder and CEO of Pearl. “With this patent, Pearl is expanding its portfolio of exclusive intellectual property, reinforcing the technological advantages and effectiveness of our dental AI solutions.”

This latest patent increases Pearl’s total number of U.S. patents to 12. Earlier this year, Pearl was issued a patent for its “Systems and Methods for Automated Medical Image Analysis,” which grants Pearl the exclusive rights to the computer system technology supporting the application programming interface (API) of its chairside AI disease detection software, Second Opinion®. Other recent patents include “Computer Vision-Based Claims Processing,” “Systems and Methods for Insurance Fraud Detection (2021)”, “Systems and Methods For Insurance Fraud Detection (2020)” and “Systems and Methods for Automated Medical Image Annotation.

exocad Introduces DentalCAD 3.2 Elefsina Software With More Than 60 New Features For More Automation And Speed

Posted on Thursday, December 21, 2023

New release offers more intuitive workflows from CAD to CAM

exocad, an Align Technology, Inc. company and a leading dental CAD/CAM software provider, today announced the release of

DentalCAD 3.2 Elefsina, the latest version of its globally renowned CAD software for labs and full-service clinics. With more than 60 new features created to optimally fulfill customers’ requirements, the software release offers new and improved workflows - from treatment planning to design and manufacturing.

DentalCAD 3.2 Elefsina delivers the exciting functionalities dental experts have been waiting for,” said Tillmann Steinbrecher, CEO of exocad. “The new release offers more automation, speed, and intuitive workflows from CAD to CAM.”

New features, more automation and seamless integration

DentalCAD 3.2 Elefsina includes many time-saving features. The new preparation margin repair tool enables users to make the most out of imperfect intraoral scans - users can fix margins to get an acceptable result despite artifacts or holes in the scan. A new auto- articulator offers fully automatic consideration of dynamic occlusion. Also included is a new integration of compact milling machines. Users can select their preferred block and start production seamlessly from within their CAD software, and switch tooth libraries while keeping their previous setup.

Elevated Smile Creator for better visualization and pre-operative treatment planning

New tools in the Smile Creator module bring users more predictability and better planning options. Users can now design virtual gingiva for more realistic outcomes and create smiles based on patients’ natural teeth. The ability to adjust the 3D rendering to the camera’s focal length enables a more precise photo-driven smile design.

Improved Bite Splint Module and Full Denture Module

With the Bite Splint Module in DentalCAD 3.2 Elefsina, users can now enjoy more automation in their bite splint design and save design time. The Full Denture Module includes a new feature to rapidly copy an existing denture in a highly automated workflow. This provides a faster and more cost-effective alternative to relining, leveraging recent advances in 3D printing. In addition, dentures on ball attachments are now supported. An add-on module for the Ivoclar Ivotion™ Denture System is now available as well, in conjunction with a dedicated tooth library, available from Ivoclar.

iTero-exocad Connector redefines seamless workflows

To improve collaboration between labs and doctors, clinicians can now share external case-related files like images, videos and X-rays with exocad DentalCAD users via the MyiTero™ portal. The new bi-directional case communication allows DentalCAD users to share their 3D designs with the doctor for an efficient preview-and-approval process. Within the CAD software, lab users can also validate margins with iTero intraoral camera images and visualize internal tooth structure with iTero NIRI (Near Infra-Red Imagery) technology.

Other major highlights of the DentalCAD 3.2 Elefsina release include:

• Design post and core restorations so that a crown matching the core can be designed in the same step (beta)

• New Virtual Articulator support for Gamma Dental Reference SL, Kavo PROTARevo 5B, plus an anatomical “in-skull” articulator visualization

• An easier and more efficient process for titanium bases supporting variable screw channel angulation

exocad will offer hands-on demonstrations of the new DentalCAD 3.2 Elefsina release at various upcoming dental exhibitions and at Insights 2024, the company’s global event, taking place May 9-10, 2024, in Palma de Mallorca, Spain. The two-day event will include numerous opportunities for attendees to discover more about the latest Elefsina features from dental industry leaders and application specialists. More information is available at

DentalCAD 3.2 Elefsina is an essential part of the Align Digital Platform™, Align’s integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners.

The release is now available in the EU and other select markets. exocad names its releases after current EU “European Capitals of Culture” and has chosen the Greek city of Elefsina for this year’s release.

Additional information is available at

MouthWatch 2023 Tellie Award Winners Demonstrate Continued Commitment to Innovation for Improved Oral Health

Posted on Thursday, December 21, 2023

MouthWatch, LLC, an industry leader in teledentistry solutions and digital imaging devices, recently announced the winners of the 6th Annual Teledentistry Innovation Awards, “The Tellies”.

The Tellies celebrate individuals, organizations, and programs that demonstrate a passion for continuous innovation, improved access to care, and better oral health through the use of teledentistry and virtual dental care applications.

“We congratulate our Tellie Award winners for their outstanding work in the communities they serve, the research they produce and for their ability to bring the success of teledentistry to the forefront in transforming care,” said Brant Herman, Founder & Chief Executive Officer of MouthWatch and Dentistry One.

The following award winners were honored at a dinner celebration held in New York City during the Greater New York Dental Meeting:

Winner Name: Marko Vujicic, Chief Economist & Vice President, American Dental Association (ADA) Health Policy Institute

Award Category: Dental Industry Innovator

As a thought leader and researcher dedicated to improvements in dentistry, Marko Vujicic leads the ADA Health Policy Institute with unwavering dedication. Through his leadership, the dental profession, patients, and industry stakeholders can depend on Mr. Vujicic and the HPI for the data and research essential to addressing the pressing issues in today's dental care system and in shaping a better tomorrow.

Winner Name: Dr. Nathan Suter

Award Category: Dental Innovator

Through his work with Enable Dental, Dr. Nathan Suter revolutionized care delivery by bringing mobile dental services directly to vulnerable populations and addressing accessibility challenges at the source. Dr. Suter's consultancy efforts have empowered dental professionals to seamlessly integrate teledentistry into their workflows, while his educational initiatives have broadened the understanding of this innovative practice. Dr. Suter’s legislative advocacy has streamlined regulations, making teledentistry more accessible.

Winner Name: Robyn Shafer, RDH

Award Category: Dental Hygiene Innovator

With only three years of experience in the field, Robyn Shafer, a dedicated dental hygienist, joined the Mainely Teeth team in October 2022. During the 2022-2023 school year, she served over thirty individual schools throughout the state, and positively impacted the lives of hundreds of students from kindergarten to 12th grade, by using teledentistry to connect with patients remotely, share documentation with family members, triage urgent cases, and refer patients to specialists.

Winner Name: Middlesex College, New Jersey

Award Category: Dental Education Innovator

Middlesex College provides dental screenings at a pre-school and a school for special needs students and uses teledentistry to make specific referrals for patients. The college’s dental hygiene students rotate through the mobile site weekly throughout the semester, with two students and one faculty member delivering care at the school clinic. Following screenings at the school for special needs students, Middlesex College offers on-site preventive treatment, leveraging teledentistry to offer synchronous or asynchronous consultations with its clinic dentist.

Winner Name: Swope Health Mobile Dental Unit

Award Category: Oral Health Program Innovator

During the 2022-2023 school year, the Swope Health Mobile Dental Unit (MDU) played a pivotal role in delivering essential preventative dentistry to 2,700 children in the Kansas City, Missouri (KCMO) and Kansas City, Kansas (KCKS) school districts, with teledentistry as the driving force behind their success.

Operating four days a week, they expertly serve over 75 schools with a single mobile unit. The program utilizes teledentistry to streamline the examination process, utilizing intraoral photos and x-rays sent asynchronously to a brick-and-mortar dental clinic for efficient treatment planning and scheduling.

“From supporting mobile services with teledentistry to reach vulnerable populations, reducing costs with virtual screenings and urgent care triage, to shaping the future of dentistry with continuous innovation, this year’s Tellie award winners are each paving the way for improved health outcomes," said Mr. Herman.

To learn more about the Teledentistry Innovation Awards and this year’s winners, visit


U.S. Oral Surgery Management Announces Eight New Partner Practices in Seven States

Posted on Thursday, December 21, 2023

Finishes 2023 Strong, Positions itself for Continued Growth

U.S. Oral Surgery Management (USOSM) has partnered with eight new partner practices in seven states: California, Colorado, Oregon, Michigan, Mississippi, South Carolina and Texas.

“In 2023, we launched our USOSM Centers of Excellence program, we implemented the USOSM Medical Mission Reimbursement Program, we secured a new $150 million credit expansion, welcomed 21 new associates and we added 25 new partner practices – eight of which, we’re announcing today,” said USOSM President and CEO Richard Hall. “We’re finishing 2023 strong and are positioned for continued growth in 2024 and beyond.”

Hall added that one of the key factors behind USOSM’s exceptional growth is the quality of its surgeon partners. “We’ve always been extremely selective about our surgeon partners. We only partner with the best-of-the-best. They’re all board certified, highly trained and highly skilled. They’re also true partners with a majority ownership stake in USOSM and complete clinical autonomy.”

USOSM’s newest partner practices include: Torrance Oral, Facial Surgery & Dental Implants; Fort Collins Oral & Maxillofacial Surgery, LLC; T. Matthew Jacks, DDS, LLC; Bingham Farms OMFS Management; Premier Oral Surgery & Implants, PLC; Harborview Oral + Facial Surgery Center; Lexington Facial & Oral Surgery; and Metroplex Surgical Arts. Collectively, they include 12 surgeons and nine locations across seven states.

About the new partners:

Established in 1968, Torrance Oral, Facial Surgery & Dental Implants is located in Torrance, California, and is led by Ramtin Vahadi, DDS, MD. Dr. Vahadi performs a full scope of oral and maxillofacial surgery (OMS) with an emphasis on dental implants and related grafting, wisdom teeth removal and outpatient anesthesia.

Located in Fort Collins, Colorado, Fort Collins Oral & Maxillofacial Surgery LLC has two doctors -- Mark F. Orr, DDS, MD and Michael Daetwyler, DDS. They offer a wide variety of OMS procedures, with expertise ranging from corrective jaw surgery to wisdom tooth removal and everything in between.

T. Matthew Jacks, DDS, LLC is located in Eugene, Oregon. Dr. Jacks specializes in complex and cosmetic facial and dental reconstructive surgery. Dr. Jacks is a former U.S. Navy Captain, who among other duties, was named the oral surgeon to the U.S. president and was responsible for the maxillofacial surgical rehabilitation of more than 100 wounded U.S. warriors.

Located in Bingham Farms, Michigan, Bingham Farms OMFS Management is led by Timothy Schmakel, DDS, MD and Derek Nykiel, DDS, MD. They offer comprehensive OMS services from dental implants to wisdom teeth removal, facial trauma treatment and more.

Premier Oral Surgery & Implants, PLC has two locations in Michigan – one in Grand Blanc and one in Lapeer. There are three doctors in the practice -- Julianna Hukill, DDS, Stephen E. Nechvatal, DMD and Leslie Orzech, DMD. They offer a full scope of OMS procedures, focused on personalized, gentle and comprehensive patient care.

Harborview Oral + Facial Surgery Center is located in Gulfport, Mississippi, and is led by Jason O. Rosetti, DDS. Dr. Rosetti provides a wide variety of OMS procedures, with particular expertise in dental implants, bone grafting and wisdom teeth removal.

Located in Lexington, South Carolina, Lexington Facial & Oral Surgery is led by Patrick A. Scioscia, DMD. Dr. Scioscia practices a full scope of OMS, from dental implant surgery and wisdom tooth removal, to corrective jaw surgery. This also includes techniques designed to rebuild bone structure with minimal surgical intervention and optimal patient comfort.

Metroplex Surgical Arts has been serving Dallas, Texas, and the surrounding areas for more than 20 years. The practice is led by Howard F. Cooke, DMD, MS. Dr. Cooke offers a full scope of OMS procedures and highly personalized patient care.

Headquartered in Irving, Texas, USOSM has partner practices spanning 26 states. A shared services organization, USOSM collaborates with premier oral and maxillofacial surgeons to offer a partnership solution for continued and accelerated practice success. USOSM provides operational, marketing and administrative support services, reinvests resources, and applies best practices to improve clinical and financial performance and produce steadier, more profitable growth for all. For more information, visit

Balanced Pharma Expands Patent Portfolio for Less Painful Dental Anesthetic

Posted on Thursday, December 21, 2023

Dentist-founded company receives additional U.S. patent for its dental cartridge technology

Balanced Pharma has received notification from the United States Patent & Trademark Office on the issuance of an additional U.S. patent for the dentist-founded company's proprietary cartridge technology. The company believes its new technology will enable dentists to deliver less painful, faster-acting, and more reliable numbing injections using a standard dental cartridge and syringe.

“This patent enhances the value of the Balanced Pharma IP portfolio by adding a third layer of protection around our dental cartridge technology in the U.S. market,” says Balanced Pharma founder and CEO, Dr. Scott Keadle.

Balanced Pharma is a pharmaceutical company headquartered near Charlotte, North Carolina, developing technology to make local anesthetic injections more comfortable for patients and more efficient for healthcare providers. BPI-001, the company’s flagship new drug candidate, is a local anesthetic intended specifically for the dental market and will be supplied in a standard dental cartridge to provide a seamless replacement for existing products, with no new training, equipment, or protocols required. The proposed product’s buffered lidocaine/epinephrine formulation will be free from the acid normally present in local anesthetics.

A large body of research shows that removing the acid from local anesthetics produces faster onset, less injection pain, and increased reliability, including a large, 2023 study1 published in the British Journal of Oral and Maxillofacial Surgery that is especially notable because of the large number of patients and statistical power of the results.

Balanced Pharma’s new drug candidate comes at a time when market research suggests that 9 out of 10 dentists would prefer a better anesthetic, and more than half of patients surveyed said the injection is the worst part of the dental experience.2

“We’re proud to be a company founded by clinicians, working together to improve patient comfort.” adds Dr. Keadle.


1. “Effectiveness of buffered and non-buffered local anaesthetic in inferior alveolar nerve block: A randomised study”, M. Bala, A.O. Taiwo, A.A. Ibikunle, H.O. Olasoji, A.O. Sulaiman, B.C. Chukwuma, R.O. Braimah, B.O. Ile-Ogedengbe; Published in the British Journal of Oral and Maxillofacial Surgery, April 21, 2023;

2. “58% of patients believe the injection is the worst part of the dental experience,” Olson Research Group, “Patient Dental Care Study Quantitative Report, Conducted for Balanced Pharma, May 7, 2021,” Fielding: March 30–April 23, 2021, total sample size: n=140 (includes 40 parents/caregivers);

“Over 90% of dentists report a desire for current anesthetics to be more reliable, less painful, or faster acting,” Olson Research Group, “Dentist Quantitative Report, Conducted for Balanced Pharma, August 13, 2021,” Fielding: June 18–July 19, 2021, total sample size: n=181;


Align Technology Receives US FDA 510(k) Clearance for the Invisalign® Palatal Expander System to Address Skeletal and Dental Expansion in Growing Patients

Posted on Tuesday, December 19, 2023

Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the U.S. Food and Drug Administration (FDA) has cleared Align’s Invisalign® Palatal Expander System* for commercial availability in the U.S. The FDA 510(k) clearance is for broad patient applicability, including growing children, teens, and adults (with surgery or other techniques).

Previously introduced at the Align Technology Investor Day in September 2023, the Invisalign Palatal Expander System is a modern and innovative direct 3D printed device based on proprietary and patented technology. Invisalign Palatal Expanders are intended for use in rapid expansion and subsequent holding of skeletal and/or dental narrow maxilla (upper jaw) with primary, mixed, or permanent dentition during treatment of patients. The Invisalign Palatal Expander is Align’s first direct 3D printed orthodontic device and provides a safe, comfortable, and clinically effective* alternative to traditional palatal expanders that require manually turning a screw in the device in the mouth daily to achieve expansion.

Speaking at the company’s 2023 Investor Day in Las Vegas, Srini Kaza, Align senior vice president of product research & development said, “I am very proud to unveil the Invisalign Palatal Expander System, our latest innovation in digital orthodontics based on proprietary and patented technology that builds on many industry firsts designed for treatment of children and teens, including Invisalign treatment with Mandibular Advancement and Invisalign First aligners. It is extremely rewarding for our team of engineers and material scientists to produce Align’s first directly fabricated orthodontic appliance and pave the way for future innovation using direct 3D printing technology that enables more sustainable and efficient solutions.”

The Invisalign Palatal Expanders consists of a series of removable devices staged in small increments of movement to expand a patient’s narrow maxilla to a position determined by their treating doctor.** Each direct 3D printed device is customized to the patient’s unique anatomy based on an iTero™ intraoral digital scan. A palatal expansion treatment plan and device design are then developed using Align’s proprietary AI-driven orthodontic software.

Combined with Invisalign First™ aligners, Invisalign Palatal Expanders provide doctors with a full early intervention treatment solution for Phase 1 treatment, an early interceptive orthodontic treatment for young patients. Phase 1 treatment is traditionally done through arch expanders or partial metal braces, before all permanent teeth have erupted – typically at ages 6 through 10. Invisalign First clear aligners are designed specifically to address a broad range of younger patients’ malocclusions, including shorter clinical crowns, management of erupting dentition, and predictable dental arch expansion***.

“The Invisalign® Palatal Expander System worked very well clinically, we had fewer emergencies and less chair time than we did with traditional expanders,” said Dr. Don Spillers, an orthodontist in Warner Robins, Georgia and participant in an Invisalign Palatal Expander clinical trial. “The experience has definitely been much better for my patients with the Invisalign Palatal Expander System, as there was no cementing of bands, no fitting of a metal expander, and no screw to turn. All of the parents were happy and their kids were cooperative.”

“Phase 1 or early interceptive treatment makes up 20 percent of orthodontic case starts each year and is growing,” said Dr. Mitra Derakhshan, Align senior vice president, Global Clinical. “Together with Invisalign First aligners, Invisalign Palatal Expanders provide doctors with a solution set to treat the most common skeletal and dental malocclusions in growing children. The addition of mandibular advancement features to Invisalign aligners also provides doctors with more options for treating skeletal and dental jaw imbalances and bite correction for their growing patients during their teenage years.”

The Invisalign Palatal Expander System is available on a limited basis in Canada and the U.S. It is expected to be available in other markets pending regulatory approvals starting in 2024.

*Based on a survey in August 2023 in Canada of 10 Invisalign trained orthodontists who participated in the Invisalign Palatal Expander System Technical Design Assessment and have treated at least 1 patient age 6-11 years with IPE. Data on file at Align Technology, Inc. as of October 30, 2023.

**Based on data from a multi-site US IDE (Investigational Device Exemption) clinical study (n=29 subjects, ages 7-10 years) of expansion treatment with Invisalign® Palatal Expanders. Data on file at Align Technology, Inc. as of October 30, 2023

***Data on File at Align Technology, Inc. as of June 2021.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for approximately 252 thousand doctor customers and are key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 26 years, Align has helped doctors treat over 16.4 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align Digital Platform™, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit for more information.

For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit For additional information about the iTero digital scanning system, please visit For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit

Invisalign, iTero, exocad, Align, and Align Digital Platform are trademarks of Align Technology, Inc.

About the Invisalign Palatal Expander System*

The Invisalign Palatal Expander System* is a modern, innovative direct 3D printed orthodontic appliance designed based on proprietary and patented technology. The Invisalign Palatal Expander System is indicated for the orthodontic treatment of malocclusion. The system is used for the rapid expansion and subsequent holding of skeletal and/or dental narrow maxilla (upper jaw, dental arch and teeth, palate) with primary, mixed, or permanent dentition during orthodontic or orthopedic treatment in children or adolescents. In adults, it is to be used in conjunction with surgery or other interventions when necessary. . Devices are 3D printed and are manufactured based on digital scan data from commercially available iTero® intraoral scanners offered by Align Technology, Ltd. The devices are removable and more hygienic than traditional appliances; manufactured to custom fit each patient’s anatomy for optimal comfort and aesthetics, expanders fit comfortably in the patient’s mouth and changed daily (no screw required).

The System is comprised of Invisalign Palatal Expanders (active expansion, each stage comes with a programmed expansion of up to 0.25mm/stage, changed daily or as per doctor’s discretion) and Invisalign Palatal Holders (copies of the last stage ​of the expansion phase designed to hold the maxilla post-active expansion and changed every 2-4 weeks as directed by the treating doctor), Invisalign Attachment Templates and proprietary 3D shape generation software.

BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser Trial

Posted on Tuesday, December 19, 2023

 BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced the successful completion of a trial program featuring the Waterlase iPlus All Tissue laser conducted by six leading U.S. dentists. The trial, led by an independent consultant, evaluated both the potential return on investment (ROI) and clinical adoption of BIOLASE's leading technology. The trial revealed unanimous doctor satisfaction with the performance and desire to recommend the purchase to others. This represented the second trial performed by dentists at a dental service organization where all the participants who evaluated the laser also purchased the unit.

"We are very pleased with the results of our trial of the Waterlase iPlus laser," said Dr. Steve Fooshee, Advanced Laser Mentor/Educator Instructor. "The laser is a valuable tool for dentists, and it has been well-received by their patients. We are confident that the laser will help dentists provide even better care to their patients."

The independent consultant and the dentists involved in the trial assessed that this advanced technology allows providers to do procedures they were not previously able to perform. This expanded capability helped keep more patients and the potential revenue associated with those patients within the practice and decreased referrals to specialists. The Waterlase iPlus laser is a versatile tool that can be used for a variety of dental procedures, including tooth extractions, periodontal surgery, and cavity fillings. The laser is also FDA-approved for use in treating periodontal disease. After an evaluation of the potential ROI, all six dentists involved in the trial elected to purchase the laser and stated that they would recommend their colleagues do the same.

"The Waterlase iPlus laser is a significant advancement in dental care," said Dr. Russell Morrow, Chief Dental Officer for BIOLASE. "It is a more precise and less invasive tool than traditional dental instruments, and it can help to reduce pain and bleeding during dental procedures. We are excited to partner with all dentists looking to adopt this advanced technology so they can take care of their patients at a higher standard and have a significant ROI on their capital equipment purchase."


BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. As of December 31, 2022, BIOLASE's proprietary laser products incorporate approximately 259 patented and 24 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. From 1998 through December 31, 2022, BIOLASE has sold over 45,500 laser systems in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at, Facebook at, Twitter at, Instagram at, and LinkedIn at

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties, including statements, regarding BIOLASE's expected revenue and revenue growth and beliefs regarding its financial resources. Forward-looking statements can be identified through the use of words such as "may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect BIOLASE's current expectations and speak only as of the date of this release. Actual results may differ materially from BIOLASE's current expectations depending upon a number of factors. These factors include, among others, the coronavirus (COVID-19) and the effects of the outbreak and actions taken in connection therewith, adverse changes in general economic and market conditions, competitive factors including but not limited to pricing pressures, the anticipated return on investment of the Waterlase iPlus All Tissue laser, and new product introductions, uncertainty of customer acceptance of new product offerings, including the Waterlase iPlus All Tissue laser, and market changes, risks associated with managing the growth of the business, and those other risks and uncertainties that are described in the "Risk Factors" section of BIOLASE's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (the "SEC") and any updates to such risk factors in subsequent filings with the SEC. Except as required by law, BIOLASE does not undertake any responsibility to revise or update any forward-looking statements.


Henry Schein Marks 25 Years of Its ‘Holiday Cheer for Children’ Program

Posted on Friday, December 15, 2023

For Two and A Half Decades, Team Schein Has Helped Spread Joy to Communities Around the World

Henry Schein, Inc. (Nasdaq: HSIC) and Team Schein Members (TSMs) from around the globe are celebrating 25 years of the Company’s “Holiday Cheer for Children” program. Since 1999, the corporate flagship initiative has helped more than 20,000 underserved children and their families experience a cheerful holiday season, with TSMs donating clothing, toys, gift cards, and more. To see highlights of the program’s 25 years, click here.

At its corporate headquarters in Melville, New York, Team Schein hosted a “Holiday Cheer for Children” event, where 100 children and their families opened presents while enjoying a fun-filled night with dinner, games, and music. In addition, 300 children received gift cards purchased through support from the Henry Schein Cares Foundation to help alleviate some of the financial burden many individuals face during the holidays.

“We are pleased to celebrate 25 years of fostering holiday joy for families all over the world,” said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. “‘Holiday Cheer for Children’ is not just an initiative, it is a reflection of Team Schein’s commitment to giving back to the communities in which we live and work. Thank you to all of Team Schein, who throughout the years, has helped keep the spirit of the program alive. We look forward to many more years of Holiday Cheer to come.”

In support of the communities surrounding the Company’s corporate headquarters, Henry Schein partnered with 10 Long Island-based social service organizations to pre-identify participating children and their families, including: Bethany House; Espoir Youth Program, Inc.; Family and Children's Association; Family Service League; Hispanic Counseling Center; Madonna Heights; Nassau County Department of Social Services; The Raymar Children's Fund; WellLife Network; and YES Community Counseling Center.

In the latest episode of #scheinchats, Henry Schein’s signature social media series, Larry Kravitz, Director of Organizational Development at Henry Schein, sat down with Mark Wenzel, Assistant Director at YES Community Counseling Center, to discuss how the program helps make the holiday season enjoyable for communities around the world.

“The ‘Holiday Cheer for Children’ program embodies the true spirit of the holidays – giving, generosity, and kindness,” said Mr. Wenzel. “From the exuberant child whose eyes light up when they receive a gift, to the grateful parent whose anxiety is relieved because they are able to purchase food for a holiday meal, this program has helped make the past 25 years unforgettable for many.”

This year, TSMs from various Company locations participated in the program, helping to brighten the holidays for more than 1,150 individuals in the United States, United Kingdom, Ireland, and Spain. “Holiday Cheer for Children” takes different forms depending on the location. The inaugural program in the United States served 200 children.

“Seeing the smiles on the faces of our students and witnessing the joy and excitement in the air were priceless moments that will be cherished by both the students and our entire school staff,” said Sinéad Toomey, Principal of Thomond Primary School in Limerick, Ireland. “The holiday season can be particularly challenging for individuals and families facing financial hardships, and Team Schein’s efforts have truly made a difference. It lifted the spirits of individuals most in need and fostered a sense of community.”

“Holiday Cheer for Children” is an initiative of Henry Schein Cares, the company’s global corporate social responsibility program, and is supported by the Henry Schein Cares Foundation, Inc., a 501(c)(3) organization that advocates and supports efforts to advance health equity and empower health care professionals to promote a healthier tomorrow.

Recent Headlines

© 2024 BroadcastMed LLC | Privacy Policy